Sex-Based Differences in Management and Outcomes of Patients Admitted or Transferred to Advanced Therapy Centers for

Ilya Kim1, Oluwatoba Akinleye2, Jaya Kanduri1

  • 1Weill Cornell Cardiovascular Outcomes Research Group (CORG), Weill Cornell Medical College, New York, NY 10021, USA.

Insights

Women with heart failure (HF) are less likely to be transferred to advanced therapy centers (ATCs). Despite similar mortality and transfer rates after adjustment, females receive fewer invasive procedures, indicating a disparity in HF management.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Heart failure (HF) presents a significant public health burden.
  • Advanced therapy centers (ATCs) improve HF procedural use and outcomes.
  • Limited data exists on sex-based disparities in ATC access and transfer patterns for HF patients.

Purpose of the Study:

  • To evaluate sex-based differences in HF management and outcomes.
  • To analyze transfer patterns to ATCs based on patient sex.
  • To assess procedural utilization across different center types and transfer statuses.

Main Methods:

  • Analysis of adult HF admissions from the 2016-19 Nationwide Readmissions Database.
  • Classification of centers performing heart transplant or LVAD as ATCs.
  • Stratification of patients by sex and center type (non-ATC, ATC, transfer to ATC) with multivariable regression.

Main Results:

  • Females were older; males had more HF decompensations.
  • Females comprised 39.6% of ATC transfers (OR 0.69, p < 0.001).
  • Adjusted transfer rates and mortality were similar, but females received fewer invasive procedures across all settings.

Conclusions:

  • Females experience lower transfer rates to ATCs.
  • In-hospital mortality and adjusted transfer rates to ATCs are similar between sexes.
  • Persistent disparities show females undergo fewer diagnostic and therapeutic interventions in HF care.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
571
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
624
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
602
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
746
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K